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RESEARCH ARTICLE
Surgical management of tuboovarian abscess: Results of retrospective case series
Tubaovaryan apsenin cerrahi yönetimi: Olgu serilerinin retrospektif sonuçları
Hüseyin Cengiz, Hediye Dağdeviren, Murat Ekin, Cihan Kaya, Şükrü Yıldız, Levent Yaşar
ÖZET
Amaç: Tubaovaryan apse (TOA) ciddi ve hayati tehlikesi 
bulunan bir durumdur. Tedavi şekilleri olarak geniş spek-
trumlu antibioterapi, minimal invaziv abse drenajı, invaziv 
cerrahi veya bu tedavi usullerinin kombinasyonunu içer-
mektedir. Bu çalışmanın amacı cerrahi olarak tedavi edil-
miş TOA olgularını değerlendirmektir.
Gereç ve yöntem: Ocak 2007-Eylül 2012 tarihleri arasın-
da Bakırköy Dr. Sadi Konuk Eğitim ve Araştırma Hastane-
si Kadın Hastalıkları ve Doğum kliniğinde yatırılıp cerrahi 
tedavisi yapılan hastalar retrospektif olarak incelendi. 
Bulgular:  TOA  olgularında  ortalama  yaş  37.2  olarak 
saptandı. Ortalama gravida ve parite sırası ile 2.9 ve 2.1 
olarak bulundu. En sık saptanan semptom olarak %47.4 
(n=27) oranı ile karın ağrısı izlendi. %49.1(n=28) hasta 
laparatomik cerrahi ve %50.9 (n=29) hasta laparaskopik 
cerrahi geçirdi. 6 hastada rüptüre TOA izlendi ve %17.9 
hastada komplikasyon gelişti. 
Sonuç:  Gerekli  cerrahi  müdahaleleri  gerçekleştirmek 
için,  açık  veya  laparoskopik  cerrahi  yaklaşımın  seçimi 
büyük ölçüde operatörün beceri, deneyim ve yeteneğine 
bağlıdır.
Anahtar kelimeler: Cerrahi, Komplikasyon, laparoskopi, 
tubaovaryan apse 
ABSTRACT
Objectives: Tuboovarian abscess (TOA) is a serious and 
potentially  life-threatening  condition.  Treatment  modali-
ties vary as broad spectrum of antibiotherapy, minimally-
invasive drainage procedures, invasive surgery or combi-
nations of these interventions. The objective of this study 
was to evaluate surgically treated patients for TOA.
Materials and methods: The medical records of 57 cas-
es who had surgically treated for TOA at Bakirkoy Dr. Sadi 
Konuk Education and Research Hospital, Department of 
Obstetrics and Gynecology from January 2007 to Sep-
tember 2012 were evaluated retrospectively.
Results: The average age was 37.2 years and the mean 
gravidity and parity were 2.9 and 2.1, respectively. The 
most common presenting symptom was abdominal pain 
47.4% (n=27). Twenty eight (49.1%) of the patients had 
laparotomy and twenty nine (50.9%) of the patients had 
laparoscopic surgery. 6 patients had a ruptured TOA and 
17.9% of the patients had complications.
Conclusions: The choice of an open or laparoscopic sur-
gical approach should be largely based on operator skill, 
experience, and ability to perform the necessary surgical 
maneuvers. J Clin Exp Invest 2012; 3(4): 463-466
Key words:  Complication,  laparoscopy,  surgery,  tubo-
ovarian abscess
INTRODUCTION
A  tuboovarian  abscess  (TOA)  is  an  inflammatory 
mass involving the fallopian tube, ovary and other 
adjacent pelvic organs (eg, bowel, bladder) occa-
sionally.1 These abscesses are seen most common-
ly in reproductive age women and typically origi-
nated from upper genital tract infection. TOA is a 
complication of pelvic inflammatory disease (PID) in 
15% of cases, and 33% of patients requiring admis-
sion with PID, have a TOA.2 TOA’s are polymicrobial 
infections and E.coli, B.fragilis, peptococci, pepto-
streptococci and mix flora especially encountered 
microorganisms in abscess cavity. The pathogen-
esis of TOA is due to fallopian tubal necrosis and 
epithelial damage by bacterial pathogens causing 
a favorable environment for anaerobic invasion and 
growth. Also these abscesses have important risk 
factors.  Some  of  these  risk  factors  are  IUD  use, 
age > 40, adoloscence, low socioeconomic status, 
multiple sex partners and nulliparity. The most im-
portant risk factor in tuba ovarian abscess formation 
is intercourse a partner having infection because of 
this disease caused by sexually transmitted infec-
tions. Malignancies, gynecological surgery, in vitro 
fertilization, perforated appendicitis and diverticulitis 
have also shown to cause abscess formation in lit-Cengiz et al. Surgical management of tuboovarian abscess 464
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erature. Also it is rarely seen in virgins. In literatue 
a few cases were published about TOA in virgin pa-
tients.3 TOA’s especially result in irreversible tubal 
and ovarian damage and this is a potential threat 
to fertility. Also this disease may be accompanied 
other complications such as incapacitating abdomi-
nal pain, ectopic pregnancy and abscess rupture. 
Aggressive medical and/or surgical therapy is re-
quired and rupture of an abscess may result in sep-
sis.4,5 Mortality associated with TOA has decreased 
dramatically  over  the  last  50  years,  however  the 
route of management varies. Treatment modalities 
include broad spectrum antibiotherapy, minimally-
invasive drainage procedures, invasive surgery, or 
combinations of these interventions.
The objective of this study was to evaluate sur-
gically treated patients for TOA.
MATERIALS AND METHODS
The medical records of the patients who had sur-
gically treated for TOA at Bakirkoy Dr. Sadi Konuk 
Education and Research Hospital, Department of 
Obstetrics and Gynecology from January 2007 to 
September  2012  were  evaluated  retrospectively. 
Patients were preoperatively diagnosed as TOA re-
lying on laboratory and ultrasonographic findings in 
the presence of a mass at the pelvic examination. 
Ultrasonographic  images  of  TOAs  were  complex 
multilocular masses that often obliterate the normal 
adnexal  architecture  and/or  cul-de-sac  anatomy, 
speckled fluid and internal echoes consistent with 
inflammatory  debris.6-8  Complications  were  de-
fined as factors that could result in prolonged hos-
pitalization as; intensive care unit (ICU) admission, 
bowel or bladder injury, blood transfusion, blood loss 
>1000 mL, sepsis or bacteremia, ileus, conversion 
from laparoscopy to laparotomy, and death. Fever 
was defined as a temperature greater than 38°C.
In our series, antibiotics were started all the pa-
tients at the admission to the hospital. After 48 to 72 
hours of treatment with antibiotics alone, patients 
who do not respond to the medical therapy or who 
had a worsen vital findings, required either minimal-
ly invasive abscess drainage or surgery. Statistical 
Analysis was performed by using the SPSS 20.0 
Statistical Software Package (SPSS, Chicago, IL, 
USA).
RESULTS
57 patients with preoperative diagnosis of TOA were 
undergone for surgical treatment. The average age 
was 37.2 years and the mean gravidity and parity 
were 2.9 and 2.1, respectively. 21.1% of the cases 
had a history of PID and 17.5% of the patients had 
smoking  habit. The  most  common  symptom  was 
abdominal pain 47.4% (n=27). 29.8% (n=17) of the 
cases had fever during admission. 49.1% (n=28) of 
the patients had laparotomy and %50.9 (n=29) had 
laparoscopic surgery.6 patients had a ruptured TOA 
and 17.9% of the patients had complications. Clini-
cal characteristics of the study population are noted 
in Table 1.
Table 1. Clinical characteristics of the patients with tubo-ovarian abscess
Mean± SD/ n % Mean± SD/n %
Age 37,2±9,1 WBC, /mm3 14254±4554
Gravidity 2,9±1,7 <10000 13 22,8%
Parity 2,1±1,2 WBC 10000 to 15000 19 33,3%
Smoking 10 17,5% >15000 25 43,9%
Previous PID 12 21,1% Abscess location Right 15 26,3%
Contraception 21 36,8% Left 29 50,9%
Pain 27 47,4% Bilateral 13 22,8%
Abnormal uterine bleeding 12 21,1% Abscess size 0-4 cm 15 26,3%
Abnormal discharge 17 29,8% 5-8 cm 28 49,1%
Fever 17 29,8% >8 cm 14 24,6%
Rebound 18 31,6% Febrile days 0 44 77,2%
Guarding 19 33,3% 1 4 7,0%
Uterine tenderness 24 42,1% 2 8 14,0%
Adnexal tenderness 24 42,1% 3 1 1,8%
Cervical motion tenderness 21 36,8% Complication 10 17,9%
Treatment laparatomy 28 49,1% Rupture 6 10,5%
Treatment laparoscopy 29 50,9% Hospitalization (Days) 6,3±3,8
PID, Pelvic inflammatory disease; WBC, White blood cells, SD= standard deviationCengiz et al. Surgical management of tuboovarian abscess 465
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Table 2. Comparison of some variables according to existence of fever in tubo-ovarian abscess patients
Febrile
Negative Positive p
Mean±SD/n % Mean±SD/n %
WBC 13250±4157 17650±4318 0,002
WBC <10000 13 29,5% 0 0,0% 0,075
10000 to 15000 14 31,8% 5 38,5%
>15000 17 38,6% 8 61,5%
Complication Negative 36 83,7% 10 76,9% 0,575
Positive 7 16,3% 3 23,1%
Hospitalization (Days) 6,5±4,1 5,5±2,3 0,075
Chi-square test / I.S t test, WBC, White blood cells, SD= standard deviation
DISCUSSION
Tuboovarian abscesses are usually found among 
reproductive age women. Abdominal pain, vaginal 
discharge and fever are usually seen in TOA pa-
tients.9 In our series, we found abdominal pain as 
the most common presenting symptom. Ginsburg 
et al10  reported  previous  PID  in TOA  patients  as 
%49. Our patients had a 21.1% previous PID rate. 
Diagnosing and managing adnexal masses can be 
problematic for physicians. A preoperative disease 
classification for patients with adnexal masses, in 
particular discrimination between benign and malig-
nant ovarian tumors, is important for optimal patient 
management.11 It is unclear whether a subjective 
evaluation of a US image (i.e., pattern recognition) 
of an adnexal mass. In one study the sensitivity of 
ultrasonography in the diagnosis of TOA was found 
as 93%, while specificity was 98.6%.12 In our daily 
practice we also use ultrasonography as a major di-
agnostic tool.
Medical  management  with  broad  spectrum 
antibiotics is now generally considered as the ini-
tial  management  for  unruptured  Tubaovarian  ab-
scess.13  TOA’s  are  polymicrobial  infections  and 
E.coli, B.fragilis, peptococci, peptostreptococci, A. 
israeli and mix flora especially encountered microor-
ganisms in abscess cavity. The 2010 Center for Dis-
ease Control and Prevention Sexually Transmitted 
Diseases Treatment Guidelines recommends inpa-
tient intravenous antibiotics for at least 24 hours. No 
specific  inpatient  antibiotic  regimen  is  suggested. 
Upon discontinuation of parenteral therapy, the CDC 
recommends that clindamycin or metronidazole be 
used with doxycycline for a total of 14 days of treat-
ment. Treatment of TOA was thought to require bi-
lateral oophorectomy and hysterectomy. However, 
optimal treatment of TOA remains unclear. Doganay 
M. et al14 aimed to find out the optimal therapau-
tic approach in patients. They were used a scoring 
system  for  defining  the  beneficial  treatment  mo-
dality. According to their study laparascopy seems 
to be the optimal treatment modality and medical 
treatment may be a reasonable alternative in well 
selected cases since it does not carry a risk of op-
erative complications. Surgery or drainage should 
be considered when the patient displays a failure to 
respond to therapy in 48 to 72 hours.15 In our clinic, 
we use the same algorithm for TOA. Today, the pref-
erable management options are minimally invasive 
technics with conservative approach. In many clin-
ics laparoscopy has been the gold standard for the 
diagnosis and treatment of TOA. Henry-Suchet et 
al carried out laparoscopic adhesiolysis and drain-
age of abscess in combination with antibiotics in 50 
women.16 In 45 patients (90%) the approach was 
successful, while five patients (10%) required fur-
ther surgery. Reich et al reported no complications 
following laparoscopic and organ-preserving man-
agement of tubo-ovarian abscess in 25 patients.17 
Raiga et al also demonstrated that operative lapa-
roscopy involving drainage of adnexal abscesses is 
a safe and effective procedure.18 In our study, 29 
patients treated laparoscopically. Buchweitz et al 
reported no complications in the patients who un-
derwent laparoscopic organ-preserving treatment.19 
We defined conversion from laparoscopy to lapa-
rotomy as a complication and we evaluate these 
cases within the laparotomy group. 10 patients had 
complications in our study but 7 of them were lapa-
roscopy to laparatomy conversion. There were two 
bowel injuries in 28 patients undergoing laparatomy. 
Only one port side infection occurred with laparos-
copy  in  29  patients  undergoing  laparoscopy. The 
limitations  of  our  study  include  a  relatively  small 
number of TOAs 
In conclusion, the choice of an open or laparo-
scopic surgical approach should be largely based Cengiz et al. Surgical management of tuboovarian abscess 466
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on operator skill, experience, and ability to perform 
the necessary surgical maneuvers given the ana-
tomical distortion.
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